Cellectis Sa Stock Revenue
| CLLS Stock | USD 1.87 0.01 0.54% |
Cellectis SA fundamentals help investors to digest information that contributes to Cellectis' financial success or failures. It also enables traders to predict the movement of Cellectis Stock. The fundamental analysis module provides a way to measure Cellectis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellectis stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 755 K | 717.2 K |
Cellectis | Revenue |
Cellectis SA Company Revenue Analysis
Cellectis' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Cellectis Revenue | 755 K |
Most of Cellectis' fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellectis SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Cellectis
Projected quarterly revenue analysis of Cellectis SA provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Cellectis match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Cellectis' stock price.
Cellectis Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Cellectis is extremely important. It helps to project a fair market value of Cellectis Stock properly, considering its historical fundamentals such as Revenue. Since Cellectis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cellectis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cellectis' interrelated accounts and indicators.
| -0.37 | -0.35 | 0.67 | -0.47 | -0.82 | ||
| -0.37 | 0.78 | -0.34 | 0.86 | 0.5 | ||
| -0.35 | 0.78 | 0.04 | 0.52 | 0.23 | ||
| 0.67 | -0.34 | 0.04 | -0.52 | -0.89 | ||
| -0.47 | 0.86 | 0.52 | -0.52 | 0.61 | ||
| -0.82 | 0.5 | 0.23 | -0.89 | 0.61 |
Click cells to compare fundamentals
Cellectis Revenue Historical Pattern
Today, most investors in Cellectis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Cellectis' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Cellectis revenue as a starting point in their analysis.
Cellectis Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Cellectis Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Cellectis SA reported 755 K of revenue. This is 99.99% lower than that of the Biotechnology sector and 99.9% lower than that of the Health Care industry. The revenue for all United States stocks is 99.99% higher than that of the company.
Cellectis Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellectis' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellectis could also be used in its relative valuation, which is a method of valuing Cellectis by comparing valuation metrics of similar companies.Cellectis is currently under evaluation in revenue category among its peers.
Cellectis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cellectis from analyzing Cellectis' financial statements. These drivers represent accounts that assess Cellectis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cellectis' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 745.4M | 1.3B | 379.2M | 96.8M | 160.4M | 152.3M | |
| Enterprise Value | 432.1M | 1.1B | 295.3M | 82.0M | 108.7M | 103.3M |
Cellectis Institutional Holders
Institutional Holdings refers to the ownership stake in Cellectis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Cellectis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Cellectis' value.| Shares | First Affirmative Financial Network | 2024-09-30 | 21.1 K | Bnp Paribas Arbitrage, Sa | 2024-06-30 | 16.7 K | Baird Financial Group, Inc. | 2024-09-30 | 15.1 K | Xtx Topco Ltd | 2024-09-30 | 13.1 K | Wells Fargo & Co | 2024-06-30 | 12.8 K | Geode Capital Management, Llc | 2024-09-30 | 10.8 K | Harbour Investments, Inc. | 2024-09-30 | 6.1 K | Rhumbline Advisers | 2024-06-30 | 3.9 K | Blackrock Inc | 2024-06-30 | 2.8 K | Long Focus Capital Management, Llc | 2024-09-30 | 4.6 M | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 1.8 M |
Cellectis Fundamentals
| Return On Equity | -0.82 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (2.34) % | ||||
| Operating Margin | (0.60) % | ||||
| Current Valuation | 11.48 M | ||||
| Shares Outstanding | 100.09 M | ||||
| Shares Owned By Insiders | 3.86 % | ||||
| Shares Owned By Institutions | 14.60 % | ||||
| Number Of Shares Shorted | 156.19 K | ||||
| Price To Earning | (14.84) X | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 5.19 X | ||||
| Revenue | 755 K | ||||
| Gross Profit | 23.95 M | ||||
| EBITDA | (98.09 M) | ||||
| Net Income | (116.83 M) | ||||
| Cash And Equivalents | 153.13 M | ||||
| Cash Per Share | 3.37 X | ||||
| Total Debt | 92.85 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 3.17 X | ||||
| Book Value Per Share | 1.29 X | ||||
| Cash Flow From Operations | (24.75 M) | ||||
| Short Ratio | 3.28 X | ||||
| Earnings Per Share | (1.16) X | ||||
| Target Price | 6.5 | ||||
| Number Of Employees | 216 | ||||
| Beta | 3.2 | ||||
| Market Capitalization | 187.18 M | ||||
| Total Asset | 334.27 M | ||||
| Retained Earnings | (405.76 M) | ||||
| Working Capital | 77.86 M | ||||
| Current Asset | 51 M | ||||
| Current Liabilities | 26.28 M | ||||
| Net Asset | 334.27 M |
About Cellectis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellectis SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellectis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellectis SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.